Troy Ignelzi
2017 - scPharmaceuticals
In 2017, Troy Ignelzi earned a total compensation of $750.8K as Chief Financial Officer at scPharmaceuticals, a 3% increase compared to previous year.
Compensation breakdown
| Bonus | $113,120 |
|---|---|
| Non-Equity Incentive Plan | $41,540 |
| Option Awards | $161,012 |
| Salary | $330,300 |
| Other | $104,800 |
| Total | $750,772 |
Ignelzi received $330.3K in salary, accounting for 44% of the total pay in 2017.
Ignelzi also received $113.1K in bonus, $41.5K in non-equity incentive plan, $161K in option awards and $104.8K in other compensation.
Rankings
In 2017, Troy Ignelzi's compensation ranked 10,296th out of 14,666 executives tracked by ExecPay. In other words, Ignelzi earned more than 29.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,296 out of 14,666 | 30th |
Division Manufacturing | 3,990 out of 5,772 | 31st |
Major group Chemicals And Allied Products | 1,405 out of 2,075 | 32nd |
Industry group Drugs | 1,142 out of 1,731 | 34th |
Industry Pharmaceutical Preparations | 891 out of 1,333 | 33rd |
Source: SEC filing on April 30, 2018.
Ignelzi's colleagues
We found three more compensation records of executives who worked with Troy Ignelzi at scPharmaceuticals in 2017.
News
Karuna Therapeutics CEO Steven Paul's 2021 pay jumps 48% to $13M
April 27, 2022
Karuna Therapeutics CEO Steven Paul's 2020 pay slips 11% to $8.9M
April 27, 2021
Karuna Therapeutics CEO Steven Paul's 2019 pay jumps 932% to $10M
April 29, 2020
scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M
April 27, 2020
scPharmaceuticals CEO John Tucker's 2018 pay falls 25% to $1.5M
April 30, 2019